Related by context. All words. (Click for frequent words.) 64 Opexa 64 INCB# [001] 63 ganetespib 62 OncoVEX GM CSF 62 picoplatin 62 obatoclax 62 elotuzumab 62 Proxinium TM 62 elacytarabine 62 R#/MEM # 62 custirsen 61 TKM ApoB 61 celgosivir 61 IMA# 61 Locteron 61 Fibrillex TM 61 eculizumab 61 OncoVEX 61 phase IIb 61 IRX 2 61 blinatumomab 61 CYT# 61 Sym# 61 CCX# 60 Archexin 60 phase IIa clinical 60 ocrelizumab 60 lomitapide 60 tanespimycin 60 HspE7 60 ISIS # 60 sapacitabine 60 Azedra 60 HQK 60 NEUMUNE 59 Triolex 59 TELCYTA 59 Phase IIa clinical 59 bardoxolone methyl 59 talactoferrin 59 otelixizumab 59 CR# vcMMAE 59 XmAb# 59 Diamyd ® 59 MAXY G# 59 Cloretazine R VNP#M 59 Alocrest 59 PXD# 59 pertuzumab 59 Phase Ib 59 Traficet EN 59 ZYBRESTAT 59 teriflunomide 59 MGCD# [001] 59 Phase Ib clinical 59 Phase 1b 58 EndoTAG TM -1 58 ASONEP 58 MOZOBIL 58 Phase IIb trials 58 confirmatory Phase III 58 vosaroxin 58 phase IIb clinical 58 Virulizin ® 58 CA4P 58 Serdaxin 58 RhuDex ® 58 CIMZIA ™ 58 Symadex 58 romidepsin 58 TRO# 58 FavId 58 registrational trial 58 PEG SN# 58 JAK inhibitor 58 NeuroVax TM 58 Alzhemed TM 58 LymphoStat B 58 apremilast 58 Tavocept 58 preclinical 58 Azedra TM 58 Phase IIb clinical 58 Phase IIa trial 58 tafamidis 58 PROSTVAC TM 58 daclizumab 58 CIMZIA TM 58 bremelanotide 58 Phenoptin 58 glufosfamide 58 HuMax EGFr 58 torezolid phosphate 58 Cinryze TM 58 GSK# [001] 58 PREOS 58 Phase 2b clinical 58 HuMax CD# 58 pradefovir 58 L MTP PE 58 GAMMAGARD 58 CoFactor 57 MAGE A3 ASCI 57 TOCOSOL Paclitaxel 57 nonclinical studies 57 perifosine 57 Amplimexon 57 PRTX 57 ADVEXIN 57 CRLX# 57 DXL# 57 MYDICAR 57 eltrombopag 57 PSN# [002] 57 HuMax CD4 57 Phase III clinical 57 Phase IIa trials 57 KNS # 57 INCB# [002] 57 Panzem R NCD 57 AVN# [001] 57 Pimavanserin 57 valopicitabine 57 Factor VIIa 57 randomized Phase IIb 57 Relivar 57 bardoxolone 57 dacetuzumab 57 GRN# 57 Amigal 57 axitinib 57 Aptivus ® 57 Phase IIb clinical trials 57 Marqibo 57 MYDICAR ® 57 randomized Phase 2b 57 bicifadine 57 forodesine 57 BiovaxID 57 EDEMA3 57 PBT2 57 Phase 2a trial 57 Fampridine SR 57 galiximab 57 Androxal TM 57 aflibercept 57 AEGR 57 rindopepimut 57 Plicera 57 Restanza 57 BCX# 57 L BLP# 57 OXi# 57 ProSavin 57 bosutinib 57 HCD# [002] 57 Bicifadine 57 teduglutide 57 JAK1 57 OvaRex R 57 HGS ETR1 56 Phase 2a clinical 56 ONCONASE R 56 Neurodex 56 urocortin 2 56 Ramoplanin 56 Phase 1b trial 56 preclinical studies 56 Prochymal 56 mertansine 56 PREOS R 56 vidofludimus 56 Asentar 56 refractory gout 56 Phase Ib study 56 pralatrexate 56 OMAPRO 56 zalutumumab 56 Phase IIb 56 Bezielle 56 Specifid 56 enzastaurin 56 decitabine 56 Panzem R 56 Phase 2b study 56 ThGRF 56 davunetide intranasal AL 56 Phase 2b trial 56 Phase 2b clinical trials 56 IMC A# 56 Phase 2b 56 baminercept 56 TRIOLEX 56 Xcellerated T Cells 56 rNAPc2 56 AeroLEF TM 56 Aryplase 56 alvespimycin 56 DR Cysteamine 56 Azixa 56 cannabinor 56 ridaforolimus 56 CRx 56 Campath alemtuzumab 56 Phase IIB 56 GRN#L 56 sargramostim 56 phase IIa 56 pegloticase 56 cangrelor 56 mifamurtide 56 HGS ETR2 56 Zerenex 56 BRAF inhibitor 56 ACTEMRA TM 56 brivaracetam 56 Technosphere Insulin 56 PEG PAL 56 Aflibercept 56 AZILECT R 56 ATL/TV# 56 ofatumumab 56 OHR/AVR# 56 vilazodone 56 Allovectin 7 R 56 PROMACTA 56 PEG Interferon lambda 56 Hyphanox 56 Virulizin R 56 Phase #b/#a 56 Valortim ® 56 ataluren 56 alvimopan 56 MEK inhibitor 56 Imprime PGG 56 Atiprimod 56 CBLC# 56 Tarvacin TM 56 Protexia R 56 Phase 2a clinical trials 56 selective androgen receptor modulator 56 mapatumumab 56 metaglidasen 56 PS# [001] 56 Ostarine 56 IMC #B 55 PRT# 55 MAXY alpha 55 registrational 55 Chrysalin 55 Aplidin 55 GFT# 55 Vitaxin 55 Dextofisopam 55 pomalidomide 55 Fx #A 55 Altastaph 55 oritavancin 55 Neuradiab 55 Anavex #-# 55 GALNS 55 dose cohort 55 Daclizumab 55 Phase Ib II 55 Mipomersen 55 AEG# 55 thymalfasin 55 Synavive 55 ponatinib 55 Tolerx 55 zanolimumab 55 Phase III trials 55 TACI Ig 55 glucokinase activator 55 EDEMA3 trial 55 NGX# 55 Vilazodone 55 #D#C# 55 tasimelteon 55 Dacogen injection 55 ELND# 55 ruxolitinib 55 PRECiSE 55 dirucotide 55 LCP Tacro 55 tgAAC# 55 Ketotransdel 55 PROCHYMAL 55 viral kinetic 55 Tamibarotene 55 MAA submission 55 PDE4 inhibitor 55 AMD# [003] 55 LE DT 55 Telintra 55 Zemplar Capsules 55 Celladon Corporation 55 tipranavir 55 oral ridaforolimus 55 GLPG# 55 favorable pharmacokinetic profile 55 romiplostim 55 tramiprosate Alzhemed TM 55 Ophena 55 TBC# 55 Phase 2a 55 UVIDEM 55 SinuNase TM 55 compound INCB# 55 BRIM2 55 Celacade TM technology 55 ApoB SNALP 55 Apoptone 55 Diamyd R 55 visilizumab 55 EGS# 55 ILLUMINATE 55 ATL# [001] 55 ganaxolone 55 YONDELIS 55 lintuzumab 55 Viramidine 55 HGS# 55 AGILECT R 55 M6G 55 reslizumab 55 CORLUX 55 maximally tolerated dose 55 ONCONASE 55 anti leukemic 55 Genasense ® oblimersen 55 IMGN# 55 ACTEMRA 55 #ME# 55 tesmilifene 55 Ticagrelor 55 Nasulin 55 BAY #-# 55 midstage clinical 55 oral prodrug 55 Phenserine 55 ANG# 55 INCB# [003] 55 entinostat 55 Pralatrexate 55 Targretin 55 dose escalation Phase 55 lumiliximab 55 dexanabinol 55 Aurexis 55 NEUVENGE 55 CEQ# 55 orBec 55 Phase IIIb clinical 55 tivozanib 55 huN# DM1 55 pafuramidine 55 farletuzumab 55 subcutaneous Herceptin 55 talabostat 55 tecarfarin 55 ALKS 55 Leukine 55 iclaprim 55 ICA # 55 ReN# 55 nicotinic alpha 7 55 Valortim 55 relapsed multiple myeloma 55 Viprinex 55 Zoraxel 55 Chemophase 55 rFIXFc 55 iloperidone 55 Zenvia ™ 55 Quinamed 55 randomized Phase 55 ALN TTR# 55 PLK1 SNALP 54 Actilon 54 cabazitaxel 54 CTAP# Capsules 54 PROVENGE 54 cilengitide 54 Troxatyl 54 Nuvion 54 omacetaxine 54 sitaxsentan 54 TroVax 54 Omigard 54 Curaxin CBLC# 54 LibiGel ® 54 Rezular 54 Phase III clinical trials 54 tocilizumab 54 Anthim 54 Genentech Roche 54 Cethromycin 54 ELND-#/AZD-# 54 oral FTY# 54 clinical pharmacology studies 54 G#DT 54 tolevamer 54 RDEA# 54 ADAGIO study 54 CD# CEA 54 faropenem 54 INT# [002] 54 PROVENGE sipuleucel T 54 fidaxomicin 54 HEPLISAV 54 Reolysin 54 bavituximab 54 AQ4N 54 CCR9 antagonist 54 ASA# 54 clinical trials 54 TPI ASM8 54 TMC# [002] 54 prucalopride 54 veltuzumab 54 TNFerade 54 PRX# 54 opioid induced bowel dysfunction 54 albinterferon alfa 2b 54 palifosfamide 54 JAK inhibitors 54 HCV protease inhibitor 54 dose escalation clinical 54 IPL# 54 rALLy trial 54 nalbuphine ER 54 CCX# B 54 EOquin TM 54 peginesatide 54 Catena ® 54 Phase 1b clinical 54 Panitumumab 54 antibody MAb 54 Phase Ia 54 investigational therapies 54 Fludara 54 Phase #/#a 54 vorinostat 54 PDX pralatrexate 54 ELACYT 54 rhThrombin 54 MEK inhibitor RDEA# 54 GRNVAC1 54 Natalizumab 54 Riquent 54 MGCD# [002] 54 IDX# 54 CGEN # 54 ZOLINZA 54 Stedivaze 54 KRN# 54 XL# [003] 54 trastuzumab DM1 T DM1 54 Ceflatonin R 54 ONTAK 54 Neo Kidney Augment 54 MEND CABG 54 Xanafide 54 AP# [003] 54 Triapine R 54 ZFP Therapeutic 54 relapsed refractory multiple myeloma 54 IND enabling 54 NLX P# 54 SNT MC# 54 darapladib 54 SinuNase 54 ularitide 54 Glufosfamide 54 volociximab 54 pharmacodynamic profile 54 LEVADEX 54 nitazoxanide 54 pexelizumab 54 lenalidomide Revlimid R 54 deforolimus 54 Phase IIa 54 APOPTONE 54 MAb 54 Oral NKTR 54 amrubicin 54 Urocidin 54 confirmatory clinical 54 preclinical efficacy 54 ISTODAX 54 vicriviroc 54 sunitinib malate 54 SparVax TM 54 ARIKACE ™ 54 budesonide foam 54 Amrubicin 54 adecatumumab 54 Campath ® 54 CD# antibody [001] 54 LT NS# 54 TELINTRA 54 TLK# 54 PSMA ADC 54 safinamide 54 Clavis Pharma 54 investigational monoclonal antibody 54 dextofisopam 54 CANCIDAS 54 seliciclib 54 StemEx 54 Phase #b/#a clinical 54 RNAi therapeutic 54 pivotal Phase III 54 EFAPROXYN 54 RhuDex 53 AzaSite Plus 53 Orazol 53 MDV# 53 Cloretazine ® 53 Stimuvax 53 Anturol 53 Naproxcinod 53 Prestara 53 Cethrin 53 LEP ETU 53 canakinumab 53 voreloxin 53 acyclovir Lauriad R 53 tolerability profiles 53 zileuton CR 53 BiTE antibody 53 Ocrelizumab 53 MEK inhibitors 53 omacetaxine mepesuccinate 53 CIMZIA TM certolizumab pegol 53 interferon gamma 1b 53 paliperidone ER 53 DexaSite 53 PF # [002] 53 mitogen activated ERK kinase 53 JAK3 53 Lu AA# 53 Menerba 53 liprotamase 53 BioMarck 53 multicenter Phase 53 ALN TTR 53 tezampanel 53 Ferumoxytol 53 PANVAC VF 53 ACZ# 53 MultiStem 53 placebo controlled Phase 53 dextromethorphan quinidine 53 CCR5 antagonist 53 Guanilib 53 ostarine 53 Carfilzomib 53 mipomersen 53 phase 2a 53 MEND CABG II 53 IIa trial 53 vernakalant oral 53 Dacogen 53 iniparib 53 OvaRex ® MAb 53 Phase III 53 Exelixis compounds 53 dimebon 53 ORENCIA R 53 clinical trial 53 epigenetic therapies 53 GLP toxicology studies 53 DDP# 53 RHUCIN 53 telbivudine 53 FOLOTYN ® 53 Corlux 53 SparVax ™ 53 GATTEX 53 phase IIb trial 53 Fodosine 53 telaprevir VX 53 Elotuzumab 53 LymphoStat B belimumab 53 Acetavance 53 EndoTAG TM 53 sodium Injection 53 Vicinium TM 53 budiodarone 53 DPX Survivac 53 LY# [003] 53 ibudilast 53 Dalbavancin 53 Metastatic Melanoma 53 Vidofludimus 53 eprotirome 53 OMS#HP 53 ALTACE 53 Locteron ® 53 cobiprostone 53 TREANDA 53 TLR agonists 53 DCVax ® 53 elagolix 53 Myocet 53 GVAX 53 Pivotal Phase 53 HEPLISAV ™ 53 BEMA TM Fentanyl 53 alagebrium 53 AMEVIVE 53 Cloretazine R 53 huC# DM4 53 pharmacodynamic properties 53 randomized discontinuation trial 53 ATryn ® 53 active comparator 53 Omacetaxine 53 XOMA 53 MBP# [001] 53 COPAXONE ® 53 midstage trials 53 XL# XL# XL# 53 Tasimelteon 53 investigational humanized monoclonal antibody 53 mGluR5 NAM 53 EnzymeRx 53 Canvaxin 53 dose escalation 53 FOLOTYN 53 AZD# 53 Symphogen 53 bafetinib 53 Protexia ® 53 MoxDuo IR 53 Tyrima 53 Mpex 53 tremelimumab 53 Trizytek 53 XL# XL# 53 Northera 53 Dyloject TM 53 Laquinimod 53 Insegia 53 candidate CRLX# 53 IL# PE#QQR 53 Liprostin 53 UPLYSO 53 Numax 53 CYCLOSET 53 SUTENT 53 Perifosine 53 CYT# potent vascular disrupting 53 PRECISE trial 53 IND submission 53 Phase III Pivotal 53 diabetic neuropathic pain 53 bevirimat 53 cathepsin K inhibitor 53 OncoGel 53 miconazole Lauriad ® 53 CAMPATH 53 VitiGam 53 Valdoxan 53 CRMD# 53 Urocortin 2 53 CD# monoclonal antibody 53 ARYx 53 targeted radiotherapeutic 53 SinuNase ™ 53 tolerability 53 Genz # 53 nimotuzumab 53 rBChE 53 Actemra tocilizumab 53 CYC# 53 Anturol TM 53 exenatide once 53 Æterna Zentaris 53 CDP# 53 tezampanel NGX# 53 Cinryze 52 HuLuc# 52 Gemzar ® 52 Microplasmin 52 TRX1 52 Junovan 52 Folotyn 52 trastuzumab Herceptin R 52 APTIVUS 52 Panzem 52 forodesine hydrochloride 52 eniluracil 52 JAK2 inhibitor 52 TEMSO 52 APEX PD 52 cancer immunotherapies 52 Scancell 52 evaluating tivozanib 52 CB2 selective receptor agonist 52 6R BH4 52 pharmacodynamic 52 integrase inhibitor 52 MYCAMINE 52 alemtuzumab Campath 52 Stimuvax R 52 Nanobody 52 icatibant 52 asenapine 52 radiation sensitizer 52 orally administered inhibitor 52 APPRAISE 52 Neo Urinary Conduit 52 liposomal formulation 52 Aquinox 52 Targeted Chemotherapy 52 IV APAP 52 AGGRASTAT R 52 velafermin 52 ONCASPAR 52 linaclotide 52 glatiramer 52 ANA# 52 CBLB# 52 fingolimod 52 Increlex ® 52 TYZEKA 52 Valortim R 52 vismodegib 52 GAP #B# 52 oral taxane 52 Kahalalide F 52 delafloxacin 52 Onalta 52 Anturol ® 52 FOLFOX6 chemotherapy regimen 52 Vion Pharmaceuticals 52 Celacade TM 52 fosbretabulin 52 Hsp# inhibitor 52 Advexin 52 Entereg R 52 Huntexil 52 TOLAMBA 52 ixabepilone 52 BYDUREON 52 SCH # 52 Lupuzor 52 cediranib 52 ascending dose 52 INC# 52 ON #.Na 52 MLN# 52 rhC1INH 52 docetaxel Taxotere R 52 Tanespimycin 52 afatinib 52 bazedoxifene 52 Fibrillex 52 tubulin inhibitor 52 IPLEX TM 52 Safinamide 52 PHX# 52 pharmacokinetic PK 52 Actemra 52 Icatibant 52 clevidipine 52 Onrigin 52 CRF1 receptor antagonist 52 oral picoplatin 52 Excellagen 52 GSK# [002] 52 Ambrisentan 52 RG# [001] 52 KSP inhibitor 52 iSONEP 52 NO# [002] 52 Alpharadin 52 placebo controlled clinical 52 GLYX 52 PROPEL trial 52 tiapamil 52 Advaxis Phase 52 Ziopharm 52 SAR# [004] 52 Sulonex 52 Fablyn 52 AVONEX ® 52 XL# XL# XL# XL# 52 Androxal 52 Talactoferrin 52 Randomized Phase 52 laquinimod 52 abiraterone acetate 52 Veronate 52 Annamycin 52 Evoltra 52 Oncophage 52 Phase IIb Trial 52 PTH analogue 52 phase IIb study 52 WILEX 52 SGS# 52 BLA submission 52 Poly ICLC 52 Excellarate 52 Hybridon 52 DAVANAT 52 REPLAGAL 52 GVAX ® 52 ENMD # 52 DAVANAT R 52 ILUVIEN ® 52 vascular disrupting agents 52 Myrexis 52 DermaVir Patch 52 Phase 1a clinical 52 QLT# 52 SUCCEED trial 52 BrachySil TM 52 proteasome inhibitor 52 Genasense ® 52 ospemifene 52 Phase Ib clinical trials 52 Pacira 52 tolerability profile 52 Angiocept 52 DASISION 52 PI3K/Akt pathway inhibitor 52 casopitant 52 oxymorphone ER 52 MERLIN TIMI 52 Behcet uveitis 52 dosing cohort 52 Q#IR 52 NXL# 52 Numoda 52 RITUXAN 52 BioNumerik 52 rilonacept 52 Clonicel 52 S/GSK# 52 low dose cytarabine 52 initiate Phase 1b 52 RSD# 52 OLEPTRO TM 52 synthetic retinoid 52 MyVax R 52 DAPT 52 imetelstat 52 GED aPC 52 sunitinib 52 Cimzia TM 52 Hedgehog Pathway Inhibitor 52 Bortezomib 52 virus HCV protease inhibitor 52 cancer neuroendocrine tumor 52 elesclomol 52 Anticalin ® 52 NP2 Enkephalin 52 BZL# 52 Cimzia ® certolizumab pegol 52 omecamtiv mecarbil 52 systemically administered 52 lurasidone 52 Phase Ib IIa 52 Allovectin 7 52 tramiprosate 52 Varespladib 52 Desmoteplase 52 metastatic HRPC 52 velaglucerase alfa 52 VAPRISOL 52 Harbor BioSciences 52 Phase IIIb 52 Phase III pivotal 52 KALBITOR 52 CUDC 52 PROVENGE ® 52 Phase IIa clinical trials 52 GEM OS2 52 REOLYSIN ® 52 pan HDAC inhibitor 52 triphendiol 52 ADVEXIN clinical 52 glatiramer acetate 52 candidates bavituximab 52 sulodexide 52 Nanobody ® 52 Firazyr 52 Solazed 52 TRAIL receptor antibodies 52 atacicept 52 ProLindac 52 mAb 52 LEVADEX ™ 52 ALN VSP 51 methylnaltrexone 51 Revimmune 51 CaPre TM 51 Preclinical studies suggest 51 lorvotuzumab mertansine 51 APF# 51 PLX cells 51 histone deacetylase HDAC inhibitor 51 Zenvia Phase III 51 NEBIDO 51 trodusquemine 51 Elocalcitol 51 Ceflatonin 51 senicapoc 51 Azedra ™ 51 PNT# 51 Gabapentin GR 51 ocular formulation 51 Elagolix 51 Removab 51 TYKERB 51 Telcyta 51 Zingo TM 51 PD LID 51 CORT # 51 depsipeptide 51 sodium thiosulfate STS 51 XOMA 3AB 51 tamibarotene 51 Clolar ® 51 Onconase 51 NV1FGF 51 StemEx R 51 dexpramipexole 51 BLP# Liposome Vaccine 51 milnacipran 51 Squalamine 51 RhuDex TM 51 therapeutic monoclonal antibody 51 NUVIGIL 51 anti CD# antibodies 51 ofatumumab HuMax CD# 51 bendamustine 51 assessing T DM1 51 etanercept Enbrel 51 carfilzomib 51 brentuximab vedotin 51 vaccines oncolytic virus 51 IAP inhibitors 51 microplasmin 51 pitavastatin 51 EVIZON 51 LAF# 51 personalized immunotherapy 51 Exelixis XL# 51 Vernakalant 51 Anticalin 51 Mr. Kriegsman 51 Vivitrex 51 Lung Rx 51 FluCide 51 Generx 51 aplindore 51 Preos 51 Onco TCS 51 TKM PLK1 51 multicenter Phase II 51 Factor Xa inhibitor 51 Sulonex TM 51 davunetide 51 EVIZON TM squalamine lactate 51 PrevOnco 51 CytoFab ™ 51 ferumoxytol 51 R#/MEM 51 RAPTIVA 51 Cannabinor 51 Genasense 51 Phase #/#a trial 51 DCVax R Brain 51 bortezomib 51 viral kinetics 51 Cloretazine 51 SILENOR 51 Phase III confirmatory 51 Emselex 51 AGGRASTAT ® 51 ATryn R 51 Transave 51 Proellex TM 51 Augment Injectable 51 NATRECOR R 51 maribavir 51 investigational drug 51 PsychoGenics 51 ancrod 51 ALN RSV# 51 Ophena TM 51 neurogenic orthostatic hypotension 51 pegylated interferons